the Third Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, 310000, China
Location status: Recruiting
NCT Number: NCT06364670
This trial aims to use machine learning to analyze fNIRS imaging data of specific brain regions of tinnitus patients, thereby constructing a predictive model of the clinical efficacy of acupuncture for SNT.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Not applicable
Hangzhou, Zhejiang, 310000, China
Location status: Recruiting
This study will recruit 500 subjects with tinnitus. Functional near-infrared spectroscopy (fNIRS) will be employed to examine specific brain regions, and the corresponding fNIRS imaging data from all detection channels will be extracted. Subsequently, the subjects will undergo a course of acupuncture treatment. Based on the recovery status of tinnitus at the conclusion of the acupuncture course, all subjects will be categorized into a "good prognosis group" and a "poor prognosis group" according to relevant efficacy criteria. The entire dataset will then be randomly divided into a training set (70%) and a test set (30%) following a 7:3 ratio.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Acupuncture will be performed at acupoints including TE17 (Yifeng), SI19 (Tinggong), GB2 (Tinghui), TE5 (Waiguan), TE3 (Zhongzhu), ST36 (Zusanli ), KI3 (Taixi), and etc.
Time frame: at baseline (pre-treatment), after 4-week treatment
RSFC will be measured by functional near-infrared spectroscopy (fNIRS).
Time frame: at baseline (pre-treatment), after 4-week treatment
Hemoglobin signals will be measured by functional near-infrared spectroscopy (fNIRS).
Time frame: at baseline (pre-treatment), after 4-week treatment
Tinnitus Severity Grading is based on relevant expert consensus.
Time frame: at baseline (pre-treatment), after 4-week treatment
Tinnitus Handicap Inventory contains 25 items, each valued at 0-4 points. A larger score indicates a more severe degree of tinnitus.
Time frame: at baseline (pre-treatment), after 4-week treatment
The average pure-tone threshold will be assessed by pure-tone audiometry.
Interested in participating?
Request InfoThe Third Affiliated hospital of Zhejiang Chinese Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07106593
Combat Disorders, Ear Diseases
San Antonio, Texas, United States
View Trial DetailsNCT07788638
Ear Diseases, Hearing Disorders
Urbana, Illinois, United States
View Trial DetailsNCT05434637
Ear Diseases, Hearing Disorders
Portland, Oregon, United States
View Trial DetailsNCT07017998
Ear Diseases, Hearing Disorders
Bozeman, Montana, United States
View Trial Details